Page 5 - Amrn News Today

GuruFocus Article or News written by GuruFocusNews and the topic is about:

Wall Street analysts expect Amarin Co. plc (NASDAQ:AMRN – Get Rating) to post sales of $104.88 million for the current quarter, according to Zacks Investment Research. Five analysts have made estimates for Amarin’s earnings. The lowest sales estimate is $84.65 million and the highest is $122.00 million. Amarin reported sales of $154.49 million in the […]

Brokerages expect that Amarin Co. plc (NASDAQ:AMRN – Get Rating) will post ($0.06) earnings per share for the current quarter, Zacks Investment Research reports. Five analysts have made estimates for Amarin’s earnings, with the highest EPS estimate coming in at ($0.03) and the lowest estimate coming in at ($0.10). Amarin posted earnings of $0.03 per […]

Amarin (NASDAQ: AMRN) recently received a number of ratings updates from brokerages and research firms: 5/27/2022 – Amarin was downgraded by analysts at StockNews.com from a “hold” rating to a “sell” rating. 5/24/2022 – Amarin had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $1.75 to $1.50. They now have […]

A number of firms have modified their ratings and price targets on shares of Amarin (NASDAQ: AMRN) recently: 5/11/2022 – Amarin was downgraded by analysts at StockNews.com from a “hold” rating to a “sell” rating. 5/6/2022 – Amarin was downgraded by analysts at JPMorgan Chase & Co. from a “neutral” rating to an “underweight” rating. […]

Wall Street brokerages expect Amarin Co. plc (NASDAQ:AMRN – Get Rating) to post sales of $104.88 million for the current fiscal quarter, Zacks reports. Five analysts have made estimates for Amarin’s earnings. The lowest sales estimate is $84.65 million and the highest is $122.00 million. Amarin reported sales of $154.49 million during the same quarter […]

MELBOURNE, Australia, May 05, 2022 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian biopharmaceutical company focused on...

Northland Securities lowered shares of Amarin (NASDAQ:AMRN – Get Rating) from an outperform rating to a market perform rating in a research report released on Wednesday, Marketbeat Ratings reports. Other research analysts have also issued research reports about the company. StockNews.com started coverage on Amarin in a report on Thursday, March 31st. They set a […]

Amarin (NASDAQ:AMRN – Get Rating) was downgraded by equities research analysts at HC Wainwright from a “buy” rating to a “neutral” rating in a research report issued to clients and investors on Thursday, The Fly reports. Other analysts have also issued reports about the company. StockNews.com assumed coverage on Amarin in a research report on […]

GuruFocus Article or News written by GuruFocusNews and the topic is about: